Immunogen | IMGN - Market Capitalization


Immunogen reported $8.72B in Market Capitalization this February of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Exelixis USD 11.75B 959M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
MacroGenics USD 102M 4M Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Novartis USD 263.08B 17.01B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 117.34B 2.45B Dec/2025